# Pharmacokinetic Study of Once Daily PMR Compared to Twice Daily Cilostazol IR Tablets in Healthy Volunteers

> **NCT03480321** · PHASE1 · COMPLETED · sponsor: **Genovate Biotechnology Co., Ltd.,** · enrollment: 21 (actual)

## Conditions studied

- Intermittent Claudication

## Interventions

- **DRUG:** Cilostazol 100 mg
- **DRUG:** PMR 150 mg
- **DRUG:** PMR 200 mg

## Key facts

- **NCT ID:** NCT03480321
- **Lead sponsor:** Genovate Biotechnology Co., Ltd.,
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-03-06
- **Primary completion:** 2018-04-28
- **Final completion:** 2018-06-07
- **Target enrollment:** 21 (ACTUAL)
- **Last updated:** 2018-07-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03480321

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03480321, "Pharmacokinetic Study of Once Daily PMR Compared to Twice Daily Cilostazol IR Tablets in Healthy Volunteers". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT03480321. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*